Myotonia
Not recruitingStudy on Long-term Safety and Efficacy of Mexiletine for Children with Myotonic Disorders
- Disease:Myotonia
- Substances:Mexiletine
France- Participants:0–17 years
- Substances:Mexiletine
- Sponsor:Lupin Europe GmbH
Rare diseases
Investigational molecules
Locations

Hanauer Landstrasse 139-143, Ostend, 60314 Frankfurt, Germany
Clinical research activity is centred on myotonic disorders, including nondystrophic myotonias and myotonic dystrophy types 1 and 2. The sponsor’s trial portfolio reflects a focused interest in symptom control for muscle stiffness and related neuromuscular manifestations.
Research in this area is directed toward patients with persistent myotonia and the clinical burden associated with inherited neuromuscular disease.
Lupin Europe GmbH runs clinical trials in conditions such as Myotonia, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.